Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Read More Pharma Industry News Clovis Oncology secures EC approval for Rubraca’s new indication in ovarian cancer treatment In a major win for Clovis Oncology, the European Commission (EC) has granted approval for an expanded indication… bypharmanewsdailyJanuary 26, 2019